Wilms’ tumor 1 (WT1), a zinc-finger transcription factor and an epigenetic modifier, has been proposed as prognostic marker of several solid and hematologic tumors because is frequently overexpressed in leukemias, lung, colon, or pancreatic cancers [11,12,13]. This evidence concerns the gene WT1 and familial pancreatic carcinoma.